Extended-release oral treprostinil in the management of pulmonary arterial hypertension: clinical evidence and experience.

about

Extended-release oral treprostinil in the management of pulmonary arterial hypertension: clinical evidence and experience.

Item

http://www.wikidata.org/entity/Q52612559

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Extended-release oral treprost ...... nical evidence and experience.

@en

Extended-release oral treprost ...... nical evidence and experience.

@nl

type

Item

label

Extended-release oral treprost ...... nical evidence and experience.

@en

Extended-release oral treprost ...... nical evidence and experience.

@nl

prefLabel

Extended-release oral treprost ...... nical evidence and experience.

@en

Extended-release oral treprost ...... nical evidence and experience.

@nl

P1476

Extended-release oral treprost ...... inical evidence and experience

@en

P2093

James C Coons

http://www.w3.org/2001/XMLSchema#string

Taylor Miller

http://www.w3.org/2001/XMLSchema#string

P2860

Smooth muscle proliferation and role of the prostacyclin (IP) receptor in idiopathic pulmonary arterial hypertension

Novel Analysis of the Oral Treprostinil Combination Therapy Trial Data.

Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial.

Experiences with treprostinil in the treatment of pulmonary arterial hypertension.

Pharmacologic therapy for pulmonary arterial hypertension in adults: CHEST guideline and expert panel report

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS):

Long-term therapy with oral treprostinil in pulmonary arterial hypertension failed to lead to improvement in important physiologic measures: results from a single center

Updated treatment algorithm of pulmonary arterial hypertension.

Efficacy and safety of oral treprostinil monotherapy for the treatment of pulmonary arterial hypertension: a randomized, controlled trial.

Recommendations for the use of oral treprostinil in clinical practice: a Delphi consensus project pulmonary circulation.

P304

1753466618766490

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1753466618766490

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

James C Coons

Taylor J Miller

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29609511

http://www.w3.org/2001/XMLSchema#string

P932

5941659

http://www.w3.org/2001/XMLSchema#string